Biologics Clinical Trials in India
At Genelife Clinical Research, we are at the forefront of groundbreaking clinical trials, specializing in a diverse array of biologic drug products including recombinant peptides, vaccines, and adenoviral vector delivery systems. As a CRO in India headquartered in Mumbai, we are dedicated to advancing the field of biologics for global pharmaceutical and biotechnology sponsors.
Biosimilar Development Expertise
With extensive experience in the clinical development of biologics, Genelife Clinical Research is a trusted partner for the successful global development of biosimilars. One of our key strengths is our comprehensive knowledge of the biologics regulatory landscape — we possess the expertise to formulate a US FDA approval strategy even in the absence of finalized guidelines.
Full Spectrum of Biologics Services
Cell Line Engineering
The foundation of any successful biologic product lies in cell line engineering. Our capabilities ensure the consistent and reliable production of high-quality biologics through validated cell line development and characterization.
Process Development
Efficient and scalable production processes are essential for biosimilar success. Our expertise in bioprocess development optimizes manufacturing processes, making them more efficient and cost-effective.
Analytical Similarity Assessment
Comprehensive physicochemical and functional characterization studies to establish analytical similarity between the biosimilar and reference biologic — a critical prerequisite for regulatory submissions.
Clinical Development
Genelife is equipped for rapid site selection, patient accrual, and expert management of early and late phase clinical trials along with PK/PD studies — optimizing trial endpoints for biosimilar approval.
Regulatory Strategy
Strategic guidance for BLA, NDA, and CDSCO biosimilar submissions — including FDA approval strategy formulation even in the absence of finalized regulatory guidelines.
Immunogenicity Studies
Design and execution of immunogenicity assessment studies — a critical component of biologic and biosimilar development programs for regulatory approval.
Biologic Drug Products We Support
- Recombinant proteins and peptides
- Monoclonal antibodies (mAbs) and biosimilars
- Vaccines (prophylactic and therapeutic)
- Adenoviral vector delivery systems
- Gene and cell therapy products
- Fusion proteins and antibody-drug conjugates (ADCs)
Genelife Clinical Research is not just developing biologic therapies — we are making them accessible to a global population. Our pioneering spirit and commitment to quality make us a preferred biologics CRO in India for sponsors bringing biosimilars to the global market.